BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:03 PM
Sep 26, 2008
 |  BC Extra  |  Top Story

GSK terminates ronacaleret Phase II trial

NPS (NASDAQ:NPSP) was down $1.05 (13%) to $7.28 on Friday after disclosing in an SEC filing that GlaxoSmithKline (LSE:GSK; NYSE:GSK) terminated a 12-month Phase II...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >